Lupin gains nearly 3% post US FDA nod to infection drug News News / News 6 years ago 433 Views comments Pharma major got the regulatorâs nod to market a generic version of Valeant Pharmaâs Ancobon capsules. Read more
News Stay interviews -- Companies#39; new tool to stop high-performers from quitting News / News - 6 years ago
News Pakistani spy accuses his agency of #39;protecting#39; terrorists: Report News / News - 6 years ago
Comments